Search
for
Sort by
Research 601–630 of 1000+
- Finasteride in the treatment of men with androgenetic alopecia
- The psychological effects of androgenetic alopecia in men
- Androgenetic alopecia in men aged 40-69 years: prevalence and risk factors
- Androgenetic Alopecia: An Evidence-Based Treatment Update
- Finasteride increases anagen hair in men with androgenetic alopecia
- Molecular basis of androgenetic alopecia: From androgen to paracrine mediators through dermal papilla
- Androgenetic alopecia present in the majority of patients hospitalized with COVID-19: The “Gabrin sign”
- Androgenetic alopecia and cardiovascular risk factors in men and women: A comparative study
- Platelet-Rich Plasma for Androgenetic Alopecia
- Androgenetic Alopecia
- Racial variations in COVID‐19 deaths may be due to androgen receptor genetic variants associated with prostate cancer and androgenetic alopecia. Are anti‐androgens a potential treatment for COVID‐19?
- Baldness and the androgen receptor: the AR polyglycine repeat polymorphism does not confer susceptibility to androgenetic alopecia
- Early Onset of Androgenetic Alopecia Associated With Early Severe Coronary Heart Disease: A Population-Based, Case-Control Study
- Pathogenesis of androgenetic alopecia
- The genetics of androgenetic alopecia
- Association of Androgenetic Alopecia With Mortality From Diabetes Mellitus and Heart Disease
- What does androgenetic alopecia have to do with COVID‐19? An insight into a potential new therapy
- Testosterone metabolism in the skin. A review of its function in androgenetic alopecia, acne vulgaris, and idiopathic hirsutism including recent studies with antiandrogens
- Androgen receptor gene polymorphisms and risk for androgenetic alopecia: a meta-analysis
- Gender-specific association of androgenetic alopecia with metabolic syndrome in a middle-aged Korean population
- Androgenetic alopecia: Quality-of-life and associated lifestyle patterns
- Promising therapies for treating and/or preventing androgenic alopecia.
- Androgenetic alopecia in adolescents: A report of 43 cases
- Androgenetic alopecia and risk of prostate cancer: A systematic review and meta-analysis
- A spilt head study of efficacy of placebo versus platelet-rich plasma injections in the treatment of androgenic alopecia
- Finasteride, a Type 2 5α-reductase inhibitor, in the treatment of men with androgenetic alopecia
- Androgenetic alopecia treated with topical minoxidil
- 5α-Reductase inhibitors in androgenetic alopecia
- Insulin-like growth factor-1: roles in androgenetic alopecia
- Evidence for two independent functional variants for androgenetic alopecia around the androgen receptor gene